Search Within

Even Holth Rustad

Formats
  1. Meeting Abstract (18)
  2. Journal Article (17)
  3. Review (5)
  4. Research Letter (3)
Groups
  1. Sloan Kettering Institute Postdocs (43)
  2. Department of Medicine (42)
  3. Hematologic Malignancies, Division of (42)
  4. Center for Hematologic Malignancies (38)
  5. Myeloma (38)
  6. Hematologic Malignancies Research (36)

More Groups

People
  1. Carl Landgren (35)
  2. Malin Hultcrantz (30)
  3. Venkata Yellapantula (28)
  4. Francesco Maura (25)
  5. Elli Papaemmanuil (18)
  6. Sham Mailankody (16)

More People

Years
  1. 2021 (8)
  2. 2020 (17)
  3. 2019 (13)
  4. 2018 (5)
Publications
  1. Blood (15)
  2. Best Practice and Research: Clinical Haematology (3)
  3. Blood Cancer Journal (3)
  4. JAMA Oncology (3)
  5. Nature Communications (3)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Nature Publishing Group (8)
  3. Elsevier Inc. (4)
  4. American Association for Cancer Research (3)
  5. American Medical Association (3)
  6. Elsevier Science, Inc. (3)

More Publishers

Results (43)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The genomic complexity of multiple myeloma precursor disease can be predicted using copy number signatures on targeted sequencing and SNP array data
    Meeting Abstract

    Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Rustad, E. H.; Diamond, B.; Hultcrantz, M.; Dogan, A.; Zhang, Y.; Morgan, G.; Landgren, O.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma: final results from a clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Diamond, B.; Salcedo, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in patients with multiple myeloma treated with continuous lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Initial whole genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
    Meeting Abstract

    Diamond, B.; Maclachlan, K. H.; Derkach, A.; Yellapantula, V.; Rustad, E. H.; Hultcrantz, M.; Shah, U. A.; Hong, J.; Landau, H. J.; Iacobuzio-Donahue, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Early relapse risk in patients with newly diagnosed multiple myeloma characterized by next-generation sequencing
    Journal Article

    D'Agostino, M.; Zaccaria, G. M.; Ziccheddu, B.; Rustad, E. H.; Genuardi, E.; Capra, A.; Oliva, S.; Auclair, D.; Yesil, J.; Colucci, P.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Accelerated single cell seeding in relapsed multiple myeloma
    Journal Article

    Landau, H. J.; Yellapantula, V.; Diamond, B. T.; Rustad, E. H.; Maclachlan, K. H.; Gundem, G.; Medina-Martinez, J.; Arango Ossa, J.; Levine, M. F.; Zhou, Y.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Baseline VDJ clonotype detection using a targeted sequencing NGS assay: Allowing for subsequent MRD assessment
    Research Letter

    Hultcrantz, M.; Rustad, E. H.; Yellapantula, V.; Arcila, M.; Ho, C.; Syed, M. H.; Papaemmanuil, E.; Zhang, Y.; Maura, F.; Landgren, O.
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma
    Journal Article

    Eveillard, M.; Rustad, E.; Roshal, M.; Zhang, Y.; Ciardiello, A.; Korde, N.; Hultcrantz, M.; Lu, S.; Shah, U.; Hassoun, H.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
    Research Letter

    Maura, F.; Rustad, E. H.; Yellapantula, V.; Łuksza, M.; Hoyos, D.; Maclachlan, K. H.; Diamond, B. T.; Greenbaum, B. D.; Morgan, G.; Lesokhin, A.; more...
    Leukemia (2020)

    Fulltext@MSK | Save
  • Timing the initiation of multiple myeloma
    Journal Article

    Rustad, E. H.; Yellapantula, V.; Leongamornlert, D.; Bolli, N.; Ledergor, G.; Nadeu, F.; Angelopoulos, N.; Dawson, K. J.; Mitchell, T. J.; Osborne, R. J.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save